Jun 5 |
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
|
Jun 5 |
Timothy Coughlin Bought 833% More Shares In aTyr Pharma
|
Jun 3 |
aTyr Pharma announces Nasdaq ticker symbol change to “ATYR”
|
Jun 3 |
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
|
May 24 |
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 15 |
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
|
May 14 |
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
|
May 6 |
aTyr Pharma to Present at Upcoming Investor Conferences
|
May 2 |
aTyr Pharma GAAP EPS of -$0.23 beats by $0.02, revenue of $0.24M beats by $0.22M
|
May 2 |
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
|